18 Feb 2021 Phase I Clinical Trial Authorisation for AVA6000 Approved by MHRA Investors | Therapeutics
23 Dec 2020 Submission of Clinical Trial Application for AVA6000 Pro-doxorubixin Investors | Therapeutics
29 Jul 2020 Expansion of Partnership with Daewoong Pharmaceutical to Include COVID-19 Neutralising Affimer Therapy Investors | Therapeutics